• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚雅加达北部老年人接受新冠病毒加强疫苗接种的支持因素和抑制因素

Supporting and inhibiting factors of accepting COVID-19 booster vaccination in the elderly in north Jakarta, Indonesia.

作者信息

Cokro Fonny

机构信息

M.Farm-Klin. Department of Pharmacy, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, 14440, Indonesia.

Department of Pharmacy, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, 14440, Indonesia.

出版信息

Pharm Pract (Granada). 2022 Oct-Dec;20(4):2748. doi: 10.18549/PharmPract.2022.4.2748. Epub 2022 Nov 11.

DOI:10.18549/PharmPract.2022.4.2748
PMID:36793907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9891777/
Abstract

BACKGROUND

The risk of fatal infection and death from Coronavirus disease 2019 (COVID-19) exposure increases in the elderly and those with coexisting illnesses such as cardiovascular disease, diabetes, cancer, obesity, and hypertension. The COVID-19 vaccine's efficacy and safety have been supported by numerous research. However, data from the Ministry of Health of Indonesia revealed that the elderly in North Jakarta had a reclining interest in receiving a booster dose. This research aimed to assess the perception of the elderly living in North Jakarta related to supporting and inhibiting factors in accepting the COVID-19 booster vaccination.

METHODS

This qualitative research used a grounded theory design. It was conducted from March to May 2022, and data were gathered in North Jakarta's numerous districts through in-depth interviews until saturation was reached. Furthermore, data were validated using member checking, source triangulation to families of elderly, and vaccination doctors. They were processed to produce transcripts, codes, and finalized themes.

RESULTS

Booster vaccination in the elderly was supported by 12 out of 15 informants, and the rest did not agree. The supporting factors include health, family, peer support, doctors, government, administrative requirements, endemic transformation, booster choice, and media coverage. Meanwhile, the inhibiting factors include hoaxes, concerns over the vaccine's safety and efficacy, political issues, family, and comorbidities.

CONCLUSIONS

Most of the elderly displayed positive attitudes concerning booster shots, but it was discovered that some barriers need to be removed.

摘要

背景

2019年冠状病毒病(COVID-19)暴露导致的致命感染和死亡风险在老年人以及患有心血管疾病、糖尿病、癌症、肥胖症和高血压等并存疾病的人群中会增加。COVID-19疫苗的有效性和安全性得到了众多研究的支持。然而,印度尼西亚卫生部的数据显示,雅加达北部的老年人对接种加强针兴趣不高。本研究旨在评估雅加达北部老年人对接受COVID-19加强疫苗接种的支持和阻碍因素的看法。

方法

本定性研究采用扎根理论设计。研究于2022年3月至5月进行,通过深入访谈在雅加达北部的多个地区收集数据,直至达到饱和。此外,通过成员核对、向老年人家庭和接种医生进行来源三角验证对数据进行了验证。对数据进行处理以生成转录本、代码和最终主题。

结果

15名受访者中有12人支持老年人接种加强针,其余人则不同意。支持因素包括健康、家庭、同伴支持、医生、政府、行政要求、疫情转变、加强针选择和媒体报道。同时,阻碍因素包括谣言、对疫苗安全性和有效性的担忧、政治问题、家庭和合并症。

结论

大多数老年人对加强针持积极态度,但发现一些障碍需要消除。

相似文献

1
Supporting and inhibiting factors of accepting COVID-19 booster vaccination in the elderly in north Jakarta, Indonesia.印度尼西亚雅加达北部老年人接受新冠病毒加强疫苗接种的支持因素和抑制因素
Pharm Pract (Granada). 2022 Oct-Dec;20(4):2748. doi: 10.18549/PharmPract.2022.4.2748. Epub 2022 Nov 11.
2
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.基于健康信念模型(HBM)的中国老年人对 COVID-19 疫苗加强针的接受情况及其影响因素:一项全国性横断面研究。
Front Public Health. 2022 Dec 15;10:986916. doi: 10.3389/fpubh.2022.986916. eCollection 2022.
3
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia.在健康成年人中,全剂量与半剂量的 COVID-19 疫苗(ChAdOx1-S 或 BNT162b2)或 CoronaVac 作为加强针接种后的免疫原性和安全性:在印度尼西亚进行的一项随机、观察者设盲、对照试验。
Lancet Infect Dis. 2023 May;23(5):545-555. doi: 10.1016/S1473-3099(22)00800-3. Epub 2023 Jan 11.
4
What Motivates People to Receive Continuous COVID-19 Vaccine Booster Shots? An Expectation Confirmation Theory Perspective.是什么促使人们接种新冠病毒持续加强针?基于期望确认理论的视角
Healthcare (Basel). 2022 Dec 14;10(12):2535. doi: 10.3390/healthcare10122535.
5
A qualitative study exploring attitudes and perceptions of the COVID-19 booster vaccine in minority ethnic individuals in North East England.一项探索英格兰东北部少数族裔个体对新冠病毒加强疫苗态度和看法的定性研究。
Z Gesundh Wiss. 2023 Feb 27:1-11. doi: 10.1007/s10389-023-01858-9.
6
Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.约旦人对接种异源新冠病毒疫苗加强针的意愿。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7516-7525. doi: 10.26355/eurrev_202112_27452.
7
Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.在奥密克戎出现后,马萨诸塞州邮政编码区域内 COVID-19 疫苗和加强针接种的不平等:一项基于人群的横断面研究。
PLoS Med. 2023 Jan 31;20(1):e1004167. doi: 10.1371/journal.pmed.1004167. eCollection 2023 Jan.
8
The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.中国60岁及以上人群对新冠病毒疫苗加强针的风险认知与犹豫态度之间的关联
Vaccines (Basel). 2022 Jul 12;10(7):1112. doi: 10.3390/vaccines10071112.
9
Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study.印度尼西亚日惹地区接受血液透析的终末期肾病患者中 COVID-19 BNT162b2 加强疫苗的免疫原性和安全性:一项队列前瞻性研究。
BMC Nephrol. 2023 May 30;24(1):151. doi: 10.1186/s12882-023-03218-x.
10
Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean.拉丁美洲和加勒比地区成年人未接种 COVID-19 疫苗加强针的流行情况及相关因素。
Travel Med Infect Dis. 2022 Nov-Dec;50:102409. doi: 10.1016/j.tmaid.2022.102409. Epub 2022 Aug 9.

引用本文的文献

1
Feasibility of Provision and Vaccine Hesitancy at a Central Hospital COVID-19 Vaccination Site in South Africa after Four Waves of the Pandemic.在南非一家中心医院新冠疫苗接种点经历四波疫情后疫苗供应的可行性及疫苗犹豫情况
Diseases. 2024 May 24;12(6):113. doi: 10.3390/diseases12060113.

本文引用的文献

1
Perceptions of and hesitancy toward COVID-19 vaccination in older Chinese adults in Hong Kong: a qualitative study.香港老年华人对 COVID-19 疫苗的认知和犹豫:一项定性研究。
BMC Geriatr. 2022 Apr 6;22(1):288. doi: 10.1186/s12877-022-03000-y.
2
Perceptions, knowledge and attitudes about COVID-19 vaccine hesitancy in older Portuguese adults.老年人对 COVID-19 疫苗犹豫的看法、知识和态度。
Age Ageing. 2022 Mar 1;51(3). doi: 10.1093/ageing/afac013.
3
Information trust and COVID-19 vaccine hesitancy amongst middle-aged and older adults in Singapore: A latent class analysis Approach.新加坡中年和老年人对信息信任和对 COVID-19 疫苗的犹豫:潜在类别分析方法。
Soc Sci Med. 2022 Mar;296:114767. doi: 10.1016/j.socscimed.2022.114767. Epub 2022 Feb 3.
4
Efficacy of COVID-19 vaccine booster doses in older people.COVID-19 疫苗加强针在老年人中的效果。
Eur Geriatr Med. 2022 Feb;13(1):275-278. doi: 10.1007/s41999-022-00615-7. Epub 2022 Jan 24.
5
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.在英国,用 ChAdOx1 nCov-19 或 BNT162b2 接种两剂后作为第三剂(加强针)接种 7 种 COVID-19 疫苗的安全性和免疫原性(COV-BOOST):一项盲法、多中心、随机、对照、2 期试验。
Lancet. 2021 Dec 18;398(10318):2258-2276. doi: 10.1016/S0140-6736(21)02717-3. Epub 2021 Dec 2.
6
Prevention of host-to-host transmission by SARS-CoV-2 vaccines.SARS-CoV-2 疫苗预防宿主间传播。
Lancet Infect Dis. 2022 Feb;22(2):e52-e58. doi: 10.1016/S1473-3099(21)00472-2. Epub 2021 Sep 14.
7
Willingness to vaccinate against Covid-19: A qualitative study involving older adults from Southern Switzerland.接种新冠疫苗的意愿:一项涉及瑞士南部老年人的定性研究。
Vaccine X. 2021 Aug;8:100108. doi: 10.1016/j.jvacx.2021.100108. Epub 2021 Jul 15.
8
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.智利开展的灭活 SARS-CoV-2 疫苗有效性研究
N Engl J Med. 2021 Sep 2;385(10):875-884. doi: 10.1056/NEJMoa2107715. Epub 2021 Jul 7.
9
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis.新型冠状病毒肺炎患者的性别、年龄及合并症与死亡率的关联:一项系统综述和荟萃分析
Intervirology. 2020 Dec 9:1-12. doi: 10.1159/000512592.
10
Comorbidity and its Impact on Patients with COVID-19.合并症及其对COVID-19患者的影响。
SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4. Epub 2020 Jun 25.